Table 2.
Hazard Ratios (HR) and 95% Confidence Intervals (95% CI) for the Ever/Never and the Current-use Analyses
| Analysis | Outcome | Unadjusted HR (95% CI) | p-value | Adjusted HR (95% CI)a | p-value |
|---|---|---|---|---|---|
| Ever/Never | Undetectable | 0.83 (0.58, 1.23) | 0.37 | 0.82 (0.58, 1.19) | 0.29 |
| Rebound | 1.51 (1.06, 2.17) | 0.02 | 1.53 (1.06, 2.19) | 0.02 | |
| Current-use | Undetectable | 0.67 (0.42, 1.07) | 0.10 | 0.65 (0.40, 1.04) | 0.07 |
| Rebound | 1.16 (0.69, 1.96) | 0.57 | 1.22 (0.72, 2.06) | 0.46 |
a
Adjusted for age, race, HIV risk factor, use of H2 receptor antagonists or anti-diarrheal medications, use of inhibitors CYP 3A, use of inducers of 2C19, and co-infection with hepatitis B or C